{
    "id": "dbpedia_8607_3",
    "rank": 21,
    "data": {
        "url": "https://www.linkedin.com/posts/dan-cocea-76b12a64_check-out-this-job-at-sandoz-romania-medical-activity-7130075871792513024-GZDA",
        "read_more_link": "",
        "language": "en",
        "title": "Dan Cocea on LinkedIn: Check out this job at Sandoz Romania: Medical Representative",
        "top_image": "https://static.licdn.com/aero-v1/sc/h/c45fy346jw096z9pbphyyhdz7",
        "meta_img": "https://static.licdn.com/aero-v1/sc/h/c45fy346jw096z9pbphyyhdz7",
        "images": [
            "https://static.licdn.com/aero-v1/sc/h/5q92mjc5c51bjlwaj3rs9aa82"
        ],
        "movies": [],
        "keywords": [],
        "meta_keywords": [
            ""
        ],
        "tags": null,
        "authors": [
            "Dan Cocea"
        ],
        "publish_date": "2023-11-14T06:15:58.212000+00:00",
        "summary": "",
        "meta_description": "Check out this job at Sandoz Romania: Medical Representative - OTC - Cluj/Sibiu/Hunedoara",
        "meta_lang": "en",
        "meta_favicon": "https://static.licdn.com/aero-v1/sc/h/al2o9zrvru7aqj8e1x2rzsrca",
        "meta_site_name": "",
        "canonical_link": "https://www.linkedin.com/posts/dan-cocea-76b12a64_check-out-this-job-at-sandoz-romania-medical-activity-7130075871792513024-GZDA",
        "text": "New consent forms introduced by ALIMS!!! The Agency for Medicines and Medical Devices of Serbia, Agencija za lekove i medicinska sredstva Srbije, known as ALIMS in the Republic of Serbia, has recently introduced new consent forms on its official website. These forms specifically pertain to the \"applicant's agreement for electronic communications regarding drugs and medical devices.\" In the event of any recent modifications concerning the individuals using electronic communication applications, responsible personnel, or other details covered by these forms, it is now imperative to complete updated consent forms. However, if there have been no alterations to the user or any other pertinent information, there is no need to submit a fresh consent form. This represents a significant stride in enhancing the efficiency and transparency of the application procedure for permits related to pharmaceuticals and medical devices. Our partner, Marija CvjetiÄ‡anin is following the development. #cvjeticaninpartners\n\nIndia's Surge in Janaushadhi Medical Stores. Key numbers: ğŸ”· Estimated 1 to 1.2 million people buy medicines daily from Janaushadhi Kendras across India. ğŸ”· During FY 2023, Pharmaceuticals and Medical Devices Bureau of India (PMBI) sold Janaushadhi medicines worth approximately â‚¹1,236 crore ğŸ”·Sales volume led to savings of around â‚¹7,416 crore for Indian citizens. ğŸ”·Prime Minister inaugurated the 10,000th Janaushadhi Kendra last year, plan to increase the number to 25,000 by FY26. ğŸ”· As of January 3, the number of Janaushadhi stores reached 10,373, offering over 1,965 drugs and 293 medical consumables and equipment #genericdrugs #indianpharma #genericmedicines\n\nAttention Medical Industry Professionals in India! The Central Government has recently issued a new order that medical doctors can only prescribe generic drugs. Means; doctors cannot prescribe any brands; only the generic names. What does this mean for the industry? Many are wondering what will happen to the favors doctors used to receive from pharma companies? Additionally, what will happen to the medical representatives roles? Will they now become retail network managers? Will the pharma companies use mass media advertising to popularise their brands? It is important to keep abreast of the latest developments in the medical industry in India. Stay informed and stay ahead of the curve. #MedicalIndustryIndia #GenericDrugs #CentralGovernmentOrder https://lnkd.in/gNh-GSta\n\nThe Therapeutic Goods Administration (TGA) has been diligently developing its Unique Device Identification (UDI) system over the past few years, involving multiple rounds of public consultation and industry feedback. As the release of UDI regulations draws near, this article offers a comprehensive overview of the TGA UDI regulatory framework and the pivotal TGA UDI Hub. For more information, click here: https://bit.ly/3w0t2sx #UDI #Australia #Regulatory #TGA\n\nThe 2024 edition of Lexology Getting The Deal Through publication Pharma & Medical Device Regulation is live. BDK Advokatiâ€™s Head of Life Sciences Bisera Andrijasevic authored the chapter on Serbia, which provides a comprehensive overview of the legislative and regulatory landscape in Serbia, including insight into the regulatory framework related to obtaining and amending marketing authorisations, clinical practice, advertising and promotion, off-label use and unlicensed products, as well as issues related to sale and supply of medicines and medical devices in Serbia. #pharma #medicaldevice #regulation #serbia\n\nCommencing on October 1, 2023, all foreign manufacturers are required to secure pre-market approval from the #CDSCO prior to the importation of medical devices and IVDs into India. Following a thorough review of the application, the CDSCO will then grant an import license. Here is a very good article going through the Indian regulatory process which I am sure you would like to #bookmark. It covers, â  ğğ«ğ¨ğœğğ¬ğ¬ ğŸğ¨ğ« ğ¨ğ›ğ­ğšğ¢ğ§ğ¢ğ§ğ  ğ¢ğ¦ğ©ğ¨ğ«ğ­ ğ¥ğ¢ğœğğ§ğ¬ğ ğŸğ«ğ¨ğ¦ ğ‚ğƒğ’ğ‚ğ, ğˆğ§ğğ¢ğš â  ğƒğğ­ğğ«ğ¦ğ¢ğ§ğ¢ğ§ğ  ğ­ğ¡ğ ğ«ğ¢ğ¬ğ¤ ğœğ¥ğšğ¬ğ¬ ğ¨ğŸ ğ¦ğğğ¢ğœğšğ¥ ğğğ¯ğ¢ğœğ ğ¨ğ« ğˆğ•ğƒğ¬ â  ğ†ğ«ğ¨ğ®ğ©ğ¢ğ§ğ  ğ¨ğŸ ğ¦ğğğ¢ğœğšğ¥ ğğğ¯ğ¢ğœğğ¬ ğšğ§ğ ğˆğ•ğƒğ¬ â  ğ€ğ©ğ©ğ¨ğ¢ğ§ğ­ğ¢ğ§ğ  ğšğ§ ğˆğ§ğğ¢ğšğ§ ğ€ğ®ğ­ğ¡ğ¨ğ«ğ¢ğ³ğğ ğ‘ğğ©ğ«ğğ¬ğğ§ğ­ğšğ­ğ¢ğ¯ğ â  ğğ«ğğ©ğšğ«ğ¢ğ§ğ  ğ’ğ®ğ›ğ¦ğ¢ğ¬ğ¬ğ¢ğ¨ğ§ ğƒğ¨ğœğ®ğ¦ğğ§ğ­ğšğ­ğ¢ğ¨ğ§ â  ğ‚ğƒğ’ğ‚ğ ğ«ğğ¯ğ¢ğğ° ğ¨ğŸ ğ­ğ¡ğ ğ¢ğ¦ğ©ğ¨ğ«ğ­ ğ¥ğ¢ğœğğ§ğ¬ğ ğšğ©ğ©ğ¥ğ¢ğœğšğ­ğ¢ğ¨ğ§ â  ğ‚ğƒğ’ğ‚ğ ğšğ©ğ©ğ«ğ¨ğ¯ğšğ¥ â  ğ‚ğƒğ’ğ‚ğ ğ‚ğ¡ğšğ«ğ ğğ¬ ğŸğ¨ğ« ğˆğ¦ğ©ğ¨ğ«ğ­ ğ‹ğ¢ğœğğ§ğ¬ğ ğ€ğ©ğ©ğ¥ğ¢ğœğšğ­ğ¢ğ¨ğ§ ğ‘ğğ¯ğ¢ğğ° If you have any questions or require assistance with the import of medical devices and IVDs in India, feel free to reach out to us at 8C Healthcare. Our experts are here to provide guidance, answer your queries, and help you with the intricacies of regulatory compliance. Contact us at contact@8chealthcare.com to get started on your journey to successfully bring your medical devices and IVDs to the Indian market. â€œğ’€ğ’ğ’–ğ’“ ğ’”ğ’–ğ’„ğ’„ğ’†ğ’”ğ’” ğ’Šğ’” ğ’ğ’–ğ’“ ğ‘­ğ’–ğ’•ğ’–ğ’“ğ’†â€. #8C #India #medical_device #regulations #IMDR2017\n\nAdvocating for fair pricing policies, Association of Indian Medical Device Industry (AIMED) urges for a separate regulatory framework tailored to the complexities of the medical devices sector. As the Department of Pharmaceuticals forms a committee to review pricing structures, industry leaders emphasize the need for equitable regulations that balance affordability and innovation. With parliamentary committees also recommending measures to support domestic manufacturing and enhance accessibility, the industry's call for reform reflects a commitment to ensuring sustainable healthcare solutions for all. Association of Indian Medical Device Industry (AIMED) Rajiv Nath Read more: https://lnkd.in/dbxJCwBx #MedicalDevices #HealthcareIndustry #RegulatoryFramework #PricingPolicies #HealthcareAccess\n\nğŸ“¢ ATTN: Manufacturers, Wholesalers, and Distributors It has come to the attention of the Medical Devicesâ€™ unit of SAHPRA that a few manufacturers, wholesalers, and distributors are still making use of the Medical Device Acknowledgement Letter in lieu of a medical device establishment licence. â— â— Please note the communication to industry that was published on 28 November 2019, Communication to Industry Licence Acknowledgement Letter, point 3 â€œPOSITION TAKEN BY SAHPRAâ€ in relation to the use of the Acknowledgement Letter in lieu of a medical device establishment licence. ğŸ‘‡ https://lnkd.in/dpayH_cw ğŸ“£ğŸ“£ğŸ“£ The use of an acknowledgement letter to sell and or distribute Medical Devices including IVDs is prohibited. #CommunicationtoIndustry #SAHPRA #MedicalDevices #IVDs #pharmaceuticalmanufacturers #pharmaceuticaldistributors #pharmaceuticalwholesalers #pharma\n\nâœ…ï¸ Diclofenac tab in Oman is not an OTC drug , so the answer in Viva Exam will be , not dispense, but, âœ…ï¸ I'll dispense for him diclofenac emugel instead to apply it at pain site... it means , systemic formulations of diclofenac \" tabs , caps , IV ... etc\" in Oman are POM , while the topical form is OTC ... ğŸ“ŒN.B: OTC = Over The Counter POM = Prescription Only Medicine â–ªï¸Viva Exam Coaching â–ªï¸ #Drug_Awareness"
    }
}